Eli Lilly's LLY Ranks 18th in Trading Volume with $2.95B Surge and 2.21% Gain as Institutional and Insider Confidence Boosts

Generated by AI AgentAinvest Volume Radar
Tuesday, Sep 16, 2025 8:20 pm ET1min read
LLY--
Aime RobotAime Summary

- Eli Lilly's LLY surged 2.21% with $2.95B trading volume, driven by institutional and insider buying, including Czech National Bank's 6.2% stake increase.

- Q3 results showed $6.31 EPS (beating estimates) and $15.56B revenue (+37.6% YoY), alongside a $1.50/share dividend yielding 0.8% annually.

- Analysts revised ratings (HSBC raised to $700, Wall Street Zen to "strong-buy"), with LLY maintaining a "Moderate Buy" consensus and $941.35 average target.

- Insiders added $2.89M in shares (directors/CEOs boosting holdings by 2.14-0.30%), while institutional ownership reached 82.53% amid 13 "Buy" ratings.

On September 16, 2025, Eli Lilly and CompanyLLY-- (LLY) saw a surge in trading activity, , , . , reflecting strong institutional and insider confidence. Institutional investors, including Salem Investment Counselors and the Czech National Bank, increased stakes in LLYLLY-- during the second quarter, . Director J Erik Fyrwald and CEO David A. Ricks also made significant insider purchases, , respectively.

The company reported robust quarterly results, , exceeding estimates, , . , . Analysts have updated their ratings, , .

, , , , . , , signaling continued support for the stock.

The backtest result indicates limitations in dynamic portfolio analysis. Current tools require a static ticker list for execution, as daily-rebalanced strategies like a "Top-500-by-Volume" portfolio are not supported. Users may narrow the scope to a fixed basket or seek conceptual guidance for indicative outcomes, though executable backtests remain unavailable under existing constraints.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet